Jonathan Bush Sells 25,000 Shares of athenahealth, Inc (ATHN) Stock

athenahealth, Inc (NASDAQ:ATHN) CEO Jonathan Bush sold 25,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $145.00, for a total value of $3,625,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Jonathan Bush also recently made the following trade(s):

  • On Thursday, February 1st, Jonathan Bush sold 5,000 shares of athenahealth stock. The stock was sold at an average price of $122.69, for a total value of $613,450.00.
  • On Wednesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The stock was sold at an average price of $134.80, for a total value of $4,044,000.00.
  • On Tuesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The stock was sold at an average price of $134.80, for a total value of $4,044,000.00.

athenahealth, Inc (ATHN) traded up $1.32 on Wednesday, reaching $134.08. The company’s stock had a trading volume of 502,293 shares, compared to its average volume of 573,919. The firm has a market cap of $5,420.00, a price-to-earnings ratio of 103.14, a P/E/G ratio of 3.18 and a beta of 1.35. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.84. athenahealth, Inc has a 12-month low of $95.01 and a 12-month high of $158.66.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.62 EPS. equities research analysts expect that athenahealth, Inc will post 2 EPS for the current year.

A number of equities research analysts have recently weighed in on ATHN shares. Piper Jaffray Companies reaffirmed a “buy” rating and set a $167.00 price target on shares of athenahealth in a research note on Tuesday, October 17th. Oppenheimer reaffirmed a “buy” rating and set a $184.00 price target on shares of athenahealth in a research note on Friday, October 20th. SunTrust Banks reaffirmed a “buy” rating and set a $156.00 price target on shares of athenahealth in a research note on Wednesday, October 25th. KeyCorp reaffirmed a “buy” rating and set a $152.00 price target on shares of athenahealth in a research note on Friday, January 12th. Finally, TheStreet downgraded athenahealth from a “b-” rating to a “c+” rating in a research note on Wednesday, October 11th. Three equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and eight have assigned a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus price target of $144.96.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. UBS Asset Management Americas Inc. grew its holdings in athenahealth by 33.2% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock valued at $4,292,000 after buying an additional 7,605 shares during the last quarter. Rockefeller Financial Services Inc. grew its holdings in athenahealth by 293.2% in the 3rd quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock valued at $1,133,000 after buying an additional 6,793 shares during the last quarter. Toronto Dominion Bank grew its holdings in athenahealth by 83.3% in the 3rd quarter. Toronto Dominion Bank now owns 220,000 shares of the health services provider’s stock valued at $27,356,000 after buying an additional 100,000 shares during the last quarter. Perceptive Advisors LLC acquired a new stake in athenahealth in the 3rd quarter valued at approximately $8,705,000. Finally, Fox Run Management L.L.C. acquired a new stake in athenahealth in the 3rd quarter valued at approximately $460,000.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/07/jonathan-bush-sells-25000-shares-of-athenahealth-inc-athn-stock.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply